| JYSZ2400037 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | License Renew | 2024-07-04 | | | | | view |
| JYSB2400218 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-09-28 | | | | | view |
| JYSB2400168 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-07-30 | | | | | view |
| JYSB2300128 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2023-08-10 | | | | | view |
| JYSB2300023 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2023-02-07 | | | | | view |
| JYSB2200185 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2022-09-26 | | | | | view |
| JYSB2101140 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-09-18 | | | | | view |
| JYSB2101105 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-08-13 | | | | | view |
| JYSB2000674 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2000352 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-07-30 | | | Filed | 2020-08-17 | view |
| JYSB2000246 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-06-20 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-06-19 | view |
| JYSB2000198 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-05-27 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
| JYSB2000139 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-01 | view |
| JYSB2000106 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-03-27 | | | Filed | 2020-04-07 | view |
| JYSB1900289 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2019-10-15 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-10-14 | view |
| JYSB1900100 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2019-05-13 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2019-05-10 | view |
| JYSB1900072 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2019-04-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-03-29 | view |
| JYSB1800256 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2018-12-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2018-11-30 | view |
| JYSB1800255 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2018-12-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2018-11-30 | view |
| JYSB1700159 | Atezolizumab注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2017-09-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2017-11-23 | view |
